Emerging Circulating Biomarkers for Enhanced Cardiovascular Risk Prediction

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology

Background:

• Cardiovascular disease (CVD) remains a leading global cause of death.
• Lipid profiles alone are insufficient for fully assessing atherosclerosis.
• Identifying novel cardiovascular risk factors and biomarkers is crucial.

Purpose of the Study:

• To review methodologies for identifying novel CVD risk factors and biomarkers.
• To discuss promising biomarkers beyond traditional lipid profiles.
• To highlight the role of inflammation, oxidative stress, and other factors in CVD.

Main Methods:

• Comprehensive literature review of methodologies for biomarker discovery.
• Analysis of existing research on inflammation, oxidative stress, plaque instability, cardiac remodeling, and fibrosis in CVD.
• Identification and discussion of specific novel biomarkers.

Main Results:

• Several key biological processes (inflammation, oxidative stress, etc.) are central to CVD pathogenesis.
• Emerging biomarkers include osteocalcin, angiogenin, lipoprotein-associated phospholipase A2, growth differentiation factor 15, galectin-3, growth stimulation expressed gene 2, and microRNAs.
• These biomarkers show potential for improving CVD risk assessment.

Conclusions:

• Novel biomarkers offer a more comprehensive approach to cardiovascular risk assessment than traditional methods.
• Further research into these biomarkers can enhance the management and prediction of CVD.
• Integrating these biomarkers may lead to personalized cardiovascular medicine.